WRF
AVNS

Waddell & Reed Financial’s Avanos Medical AVNS Stock Holding History

Waddell & Reed Financial’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-45,500
Closed -$1.84M – 614
2015
Q2 		$1.84M Sell
45,500
-223,200
-83% -$10M ﹤0.01% 576
2015
Q1 		$13.2M Buy
+268,700
New +$12.4M 0.02% 398

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Waddell & Reed Financial's AVNS Position: Q3 2015 in Review

Waddell & Reed Financial sold out of Avanos Medical (AVNS) in Q3 2015, closing a stake of 45,500 shares — an estimated $1.84M sold.

Waddell & Reed Financial first reported a position in AVNS in Q1 2015 and held it in 2 quarters. The position peaked at $13.2M in Q1 2015. 353 funds tracked by Wall St. Rank hold AVNS as of Q3 2015.

  • Waddell & Reed Financial reported no remaining Avanos Medical position as of Q3 2015 after selling out during the quarter.
  • Waddell & Reed Financial sold 45,500 Avanos Medical shares in Q3 2015, an estimated $1.84M.
  • Waddell & Reed Financial first reported a position in Avanos Medical in Q1 2015 and held it in 2 quarters.
  • Waddell & Reed Financial's Avanos Medical position peaked at $13.2M in Q1 2015.
  • 353 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2015.

Based on Waddell & Reed Financial's 13F filing for Q3 2015, filed 13 Nov 2015.